PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.85%
Revenue growth above 1.5x MRVL's 0.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.82%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
23.29%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
31.03%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
-1.96%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-2.65%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.03%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.11%
Share reduction more than 1.5x MRVL's 4.89%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.22%
Diluted share reduction more than 1.5x MRVL's 0.69%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.13%
Maintaining or increasing dividends while MRVL cut them. John Neff might see a strong edge in shareholder returns.
-16.10%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-18.43%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
31.77%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
23.77%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-0.08%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
41.36%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
13.88%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
-9.71%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
103.37%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
88.52%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
13.44%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
7.90%
Below 50% of MRVL's 62.87%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.15%
Negative 5Y equity/share growth while MRVL is at 9.47%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-18.37%
Negative 3Y equity/share growth while MRVL is at 31.11%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
644.90%
Dividend/share CAGR of 644.90% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
163.60%
5Y dividend/share CAGR above 1.5x MRVL's 0.01%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
79.57%
3Y dividend/share CAGR above 1.5x MRVL's 0.01%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
18.37%
AR growth well above MRVL's 9.38%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.00%
Inventory is declining while MRVL stands at 28.23%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.37%
Asset growth 1.25-1.5x MRVL's 3.23%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
8.79%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
0.01%
Debt shrinking faster vs. MRVL's 20.83%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
1.85%
R&D growth drastically higher vs. MRVL's 0.54%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.50%
SG&A declining or stable vs. MRVL's 4.39%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.